These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 2876685)

  • 1. Pharmacological study of basal acid secretion by the rat isolated fundus preparation.
    Coruzzi G; Adami M; Bertaccini G; Canfield SP
    Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):140-50. PubMed ID: 2876685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
    Wallmark B; Lorentzon P; Larsson H
    Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated gastric mucosa: an early approach to the study of the mechanism of action of gastric antisecretory agents.
    Colombo M; Fort M; Farré AJ
    Methods Find Exp Clin Pharmacol; 1989 Oct; 11(10):621-34. PubMed ID: 2573753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of H2-receptor antagonists upon physiological acid secretory states in animals.
    Pendleton RG; Cook PG; Shepherd-Rose A; Mangel AW
    J Pharmacol Exp Ther; 1985 Apr; 233(1):64-9. PubMed ID: 2858583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of acid secretion.
    Schubert ML; Shamburek RD
    Gastroenterol Clin North Am; 1990 Mar; 19(1):1-25. PubMed ID: 1691738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a conscious rat model for the discovery of novel agents that inhibit gastric acid secretion.
    Campbell CA; Gaskin PJ; Darton J; Chiu P; Lee K; McLean PG
    Eur J Pharmacol; 2008 Jul; 589(1-3):260-3. PubMed ID: 18571645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
    Shamburek RD; Schubert ML
    Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between histaminergic and cholinergic pathways of gastric motility regulation.
    Milenov K; Todorov S; Vassileva M; Zamfirova R; Shahbazian A
    Methods Find Exp Clin Pharmacol; 1996; 18(1):33-9. PubMed ID: 8721254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lafutidine, a unique histamine H2-receptor antagonist, inhibits distention-induced gastric acid secretion through an H2 receptor-independent mechanism.
    Nakano M; Kitano S; Nanri M; Kiniwa M
    Eur J Pharmacol; 2011 May; 658(2-3):236-41. PubMed ID: 21349265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ORF 17583, other histamine H2-receptor antagonists and omeprazole on gastric acid secretory states in rats and dogs.
    Katz LB; Tobia AJ; Shriver DA
    J Pharmacol Exp Ther; 1987 Aug; 242(2):437-42. PubMed ID: 2886642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study with oxmetidine and ranitidine on acid secretion and gastrin release in the dog.
    Soldani G; Del Tacca M; Polloni A; Bernardini C; Martinotti E
    Int J Tissue React; 1984; 6(2):181-4. PubMed ID: 6145677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of gastric acid secretion in vivo and in vitro by an inhibitor of Cl(-)-HCO3- exchanger, 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid.
    Horie S; Yano S; Watanabe K
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1313-8. PubMed ID: 8510011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
    Amagase K; Kato S; Yamamoto H; Okabe S
    Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs.
    Lin TM; Evans DC; Warrick MW; Pioch RP
    J Pharmacol Exp Ther; 1986 Nov; 239(2):406-10. PubMed ID: 2877081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoregulation of enterochromaffin-like cell histamine secretion via the histamine 3 receptor subtype.
    Kidd M; Tang LH; Miu K; Lawton GP; Sandor A; Modlin IM
    Yale J Biol Med; 1996; 69(1):9-19. PubMed ID: 9041685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of histamine and of some H2-antagonists on gastric secretion 'in vitro'.
    Coruzzi G; Adami M; Bertaccini G
    Agents Actions; 1984 Apr; 14(3-4):516-21. PubMed ID: 6145338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of secretagogue selection on potency determinations for gastric acid antisecretory agents.
    Palumbo GJ; Nielsen ST
    Methods Find Exp Clin Pharmacol; 1988 Mar; 10(3):151-5. PubMed ID: 2898575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural modification of H2-receptor antagonists provide post-H2-receptor gastric antisecretory activity.
    Nielsen ST; Dove PA; Strike DP; Schiehser GA
    Drugs Exp Clin Res; 1987; 13(5):297-304. PubMed ID: 2890506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different effects of H1 and H2 blockers on the tone and the contractile activity of guinea pig stomach fundus.
    Milenov K; Todorov S; Vassileva M; Zamfirova R; Shahbazian A
    Methods Find Exp Clin Pharmacol; 1995 Nov; 17(9):609-13. PubMed ID: 8786675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the H2 receptor antagonist and gastric acid antisecretory properties of Wy-45,727.
    Nielsen ST
    J Pharmacol Exp Ther; 1987 Aug; 242(2):607-13. PubMed ID: 2886646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.